Who we are :
Based on 10 years of scientific research, NETRI has developped a unique know-how in designing multiple organs/organoids on chip by integrating disruptive building blocks into the same microfluidic devices, while maintaining industrial production stantards compatible with pharmaceutical industry equipments.
Thanks to our patented technologies, we are capable of manufacturing prototypes and validate their biological functions using rodent or human cells. Our unique infrastructure allows us also to scale up chip production for mass production.
Our standard or customer-inspired devices are designed to accelerate the development time for new treatments by :
Translating human physiology into organ on chip with high throughput industrial capacity
Ensuring reproducible readouts for mode of action exploration, including axonal transport, growth, regeneration and axotomy, synaptic toxicity, viral and protein propagation, organoids and electrophysiological recordings
Developing robust, automated and parallelised organ on chip technologies applicable in industry, with medium to high throughput capacity, reliability and repeatability, using validated and standardised tools and methods.
Latest News
Keep in touch with us and read about our latest news.
Thibault Honegger, PDG et Co-Fondateur de NETRI, dans Le Magazine Biovalley France
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
NETRI présentée dans Capital, édition “Réussite à la française”
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
NeoBento™ : new container for NETRI microfluidic chips
NETRI has developed key and unique technologies that allow to produce reproducible, close to human physiopathology, reliable and easy to use organ-on-chip!
